Multicenter phase II study of the combination of carboplatin and paclitaxel as first line treatment in elderly patients with advanced non small cell lung cancer (NSCLC)

7239 Purpose: Thirty percent of NSCLC arise in patients over 70 years. The purpose of this phase II trial is to evaluate the efficacy and the safety of the combination of carboplatin and paclitaxel...